Research progress of obesity-related tumors

doi:10.3877/cma.j.issn.2095-9605.2023.03.005

Abstract

Abstract:

Obesity can promote the development of tumors through accelerating chronic inflammation, hyperinsulinemia, hypercirculating steroid hormonemia, hypergycemia, hyperlipemia and the production of cytokines and growth factors. Herein, the recent literatures about the development of obesity-related tumors and the phenomenon of obesity paradox are reviewed briefly. And we summarize the current status of bariatric surgery to prevent obesity-related tumors.

Key words: Obesity, Tumor, Obesity-related tumors, Bariatric surgery, Obesity paradox

Xiaoxuan Fan, Na Wang, Lihua Zhu, Liang Wang. Research progress of obesity-related tumors[J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2023, 09(03): 173-178.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhfpydxbdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-9605.2023.03.005

https://zhfpydxbdzzz.cma-cmc.com.cn/EN/Y2023/V09/I03/173

Figures/Tables 1

References 53

[1]	Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013 [J]. The Lancet, 2014, 384(9945): 766-781.
[2]	Bhaskaran K, Douglas I, Forbes H, et al. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults [J]. The Lancet, 2014, 384(9945): 755-765.
[3]	Arnold M, Pandeya N, Byrnes G, et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study [J]. The Lancet Oncology, 2015, 16(1): 36-46.
[4]	Lauby-Secretan B, Scoccianti C, Loomis D, et al. Body Fatness and Cancer — Viewpoint of the IARC Working Group [J]. New England Journal of Medicine, 2016, 375(8): 794-798.
[5]	Hotamisligil GS. Inflammation and metabolic disorders [J]. Nature, 2006, 444(7121): 860-867.
[6]	Kryston TB, Georgiev AB, Pissis P, et al. Role of oxidative stress and DNA damage in human carcinogenesis [J]. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2011, 711(1-2): 193-201.
[7]	Savini I, Catani M, Evangelista D, et al. Obesity-Associated Oxidative Stress: Strategies Finalized to Improve Redox State [J]. International Journal of Molecular Sciences, 2013, 14(5): 10497-10538.
[8]	Luperini BCO, Almeida DC, Porto MP, et al. Gene polymorphisms and increased DNA damage in morbidly obese women [J]. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2015, 776(1-2): 111-117.
[9]	Pelucchi C, Serraino D, Negri E, et al. The Metabolic Syndrome and Risk of Prostate Cancer in Italy [J]. Annals of Epidemiology, 2011, 21(11): 835-841.
[10]	Tian Y, Wang K, Li J, et al. The association between serum lipids and colorectal neoplasm: a systemic review and meta-analysis [J]. Public Health Nutrition, 2015, 18(18): 3355-3370.
[11]	Gallagher EJ, Zelenko Z, Neel BA, et al. Elevated tumor LDLR expression accelerates LDL cholesterol-mediated breast cancer growth in mouse models of hyperlipidemia [J]. Oncogene, 2017, 36(46): 6462-6471.
[12]	Jin Y, Yang T, Li D, et al. Effect of dietary cholesterol intake on the risk of esophageal cancer: a meta-analysis [J]. Journal of International Medical Research, 2019, 47(9): 4059-4068.
[13]	Ringel AE, Drijvers JM, Baker GJ, et al. Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity [J]. Cell, 2020, 183(7): 1848-1866. e26.
[14]	Danilo C, Gutierrez-Pajares JL, Mainieri MA, et al. Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development [J]. Breast Cancer Research, 2013, 15(5): R87.
[15]	Gordon JA, Noble JW, Midha A, et al. Upregulation of Scavenger Receptor B1 Is Required for Steroidogenic and Nonsteroidogenic Cholesterol Metabolism in Prostate Cancer [J]. Cancer Research, 2019, 79(13): 3320-3331.
[16]	Guillaumond F, Bidaut G, Ouaissi M, et al. Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma [J]. Proceedings of the National Academy of Sciences, 2015, 112(8): 2473-2478.
[17]	Graziani SR, Igreja FAF, Hegg R, et al. Uptake of a Cholesterol-Rich Emulsion by Breast Cancer [J]. Gynecologic Oncology, 2002, 85(3): 493-497.
[18]	Pascual G, Avgustinova A, Mejetta S, et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36 [J]. Nature, 2017, 541(7635): 41-45.
[19]	Ladanyi A, Mukherjee A, Kenny HA, et al. Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis [J]. Oncogene, 2018, 37(17): 2285-2301.
[20]	Michelet X, Dyck L, Hogan A, et al. Metabolic reprogramming of natural killer cells in obesity limits antitumor responses [J]. Nature Immunology, 2018, 19(12): 1330-1340.
[21]	Wang H, Franco F, Tsui Y-C, et al. CD36-mediated metabolic adaptation supports regulatory T cell survival and function in tumors [J]. Nature Immunology, 2020, 21(3): 298-308.
[22]	Iyengar P, Espina V, Williams TW, et al. Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment [J]. Journal of Clinical Investigation, 2005, 115(5): 1163-1176.
[23]	Sheng X, Parmentier J-H, Tucci J, et al. Adipocytes Sequester and Metabolize the Chemotherapeutic Daunorubicin [J]. Molecular Cancer Research, 2017, 15(12): 1704-1713.
[24]	Su F, Ahn S, Saha A, et al. Adipose stromal cell targeting suppresses prostate cancer epithelial-mesenchymal transition and chemoresistance [J]. Oncogene, 2019, 38(11): 1979-1988.
[25]	Reggiani F, Labanca V, Mancuso P, et al. Adipose Progenitor Cell Secretion of GM-CSF and MMP9 Promotes a Stromal and Immunological Microenvironment That Supports Breast Cancer Progression [J]. Cancer Research, 2017, 77(18): 5169-5182.
[26]	Saha A, Ahn S, Blando J, et al. Proinflammatory CXCL12-CXCR4/CXCR7 Signaling Axis Drives Myc-Induced Prostate Cancer in Obese Mice [J]. Cancer Research, 2017, 77(18): 5158-5168.
[27]	Qian B-Z, Pollard JW. Macrophage Diversity Enhances Tumor Progression and Metastasis [J]. Cell, 2010, 141(1): 39-51.
[28]	Arendt LM, McCready J, Keller PJ, et al. Obesity Promotes Breast Cancer by CCL2-Mediated Macrophage Recruitment and Angiogenesis [J]. Cancer Research, 2013, 73(19): 6080-6093.
[29]	Kuang D-M, Zhao Q, Peng C, et al. Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1 [J]. Journal of Experimental Medicine, 2009, 206(6): 1327-1337.
[30]	Springer NL, Iyengar NM, Bareja R, et al. Obesity-Associated Extracellular Matrix Remodeling Promotes a Macrophage Phenotype Similar to Tumor-Associated Macrophages [J]. The American Journal of Pathology, 2019, 189(10): 2019-2035.
[31]	Iyengar NM, Zhou XK, Gucalp A, et al. Systemic Correlates of White Adipose Tissue Inflammation in Early-Stage Breast Cancer [J]. Clinical Cancer Research, 2016, 22(9): 2283-2289.
[32]	Morris PG, Hudis CA, Giri D, et al. Inflammation and Increased Aromatase Expression Occur in the Breast Tissue of Obese Women with Breast Cancer [J]. Cancer Prevention Research, 2011, 4(7): 1021-1029.
[33]	Bowers LW, Brenner AJ, Hursting SD, et al. Obesity-associated systemic interleukin-6 promotes pre-adipocyte aromatase expression via increased breast cancer cell prostaglandin E2 production [J]. Breast Cancer Research and Treatment, 2015, 149(1): 49-57.
[34]	Maffei M, Halaas J, Ravussin E, et al. Leptin levels in human and rodent: Measurement of plasma leptin and ob RNA in obese and weight-reduced subjects [J]. Nature Medicine, 1995, 1(11): 1155-1161.
[35]	Andò S, Gelsomino L, Panza S, et al. Obesity, Leptin and Breast Cancer: Epidemiological Evidence and Proposed Mechanisms [J]. Cancers, 2019, 11(1): 62.
[36]	Zheng Q, Dunlap SM, Zhu J, et al. Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival [J]. Endocrine-Related Cancer, 2011, 18(4): 491-503.
[37]	Wang Z, Aguilar EG, Luna JI, et al. Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade [J]. Nature Medicine, 2019, 25(1): 141-151.
[38]	Murphy KA, James BR, Sjaastad FV, et al. Cutting Edge: Elevated Leptin during Diet-Induced Obesity Reduces the Efficacy of Tumor Immunotherapy [J]. The Journal of Immunology, 2018, 201(7): 1837-1841.
[39]	Wrann CD, Laue T, Hübner L, et al. Short-term and long-term leptin exposure differentially affect human natural killer cell immune functions [J]. American Journal of Physiology-Endocrinology and Metabolism, 2012, 302(1): E108-E116.
[40]	Sepesi B, Gold K A, Correa A M, et al. The Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non–Small Cell Lung Cancer [J]. Journal of Thoracic Oncology, 2017, 12(8): 1280-1287.
[41]	McQuade JL, Daniel CR, Hess KR, et al. Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis [J]. The Lancet Oncology, 2018, 19(3): 310-322.
[42]	Kichenadasse G, Miners JO, Mangoni AA, et al. Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non–Small Cell Lung Cancer [J]. JAMA Oncology, 2020, 6(4): 512.
[43]	Webb PM. Commentary: Weight gain, weight loss, and endometrial cancer[J]. International Journal of Epidemiology, 2006, 35(1): 166-168.
[44]	Sjöström L, Larsson B, Carlsson B, et al. Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects [J]. New England Journal of Medicine, 2007, 357(8): 741-752.
[45]	Adams TD, Stroup AM, Gress RE, et al. Cancer Incidence and Mortality After Gastric Bypass Surgery [J]. Obesity, 2009, 17(4): 796-802.
[46]	Aminian A, Wilson R, Al-Kurd A, et al. Association of Bariatric Surgery With Cancer Risk and Mortality in Adults With Obesity [J]. JAMA, 2022, 327(24): 2423.
[47]	Bonovas S, Filioussi K, Sitaras NM. Statin use and the risk of prostate cancer: A metaanalysis of 6 randomized clinical trials and 13 observational studies: Statin Use and Prostate Cancer Risk [J]. International Journal of Cancer, 2008, 123(4): 899-904.
[48]	Manthravadi S, Shrestha A, Madhusudhana S. Impact of statin use on cancer recurrence and mortality in breast cancer: A systematic review and meta-analysis: Breast cancer: A systematic review and meta-analysis [J]. International Journal of Cancer, 2016, 139(6): 1281-1288.
[49]	Scully T, Ettela A, LeRoith D, et al. Obesity, Type 2 Diabetes, and Cancer Risk [J]. Frontiers in Oncology, 2021, 10: 615375.
[50]	Lengyel E, Makowski L, DiGiovanni J, et al. Cancer as a Matter of Fat: The Crosstalk between Adipose Tissue and Tumors [J]. Trends in Cancer, 2018, 4(5): 374-384.
[51]	Quail DF, Dannenberg AJ. The obese adipose tissue microenvironment in cancer development and progression [J]. Nature Reviews Endocrinology, 2019, 15(3): 139-154.
[52]	Stancu C, Sima A. Statins: mechanism of action and effects [J]. Journal of Cellular and Molecular Medicine, 2001, 5(4): 378-387.
[53]	Murtola TJ, Syvälä H, Pennanen P, et al. The Importance of LDL and Cholesterol Metabolism for Prostate Epithelial Cell Growth [J]. I. Agoulnik. PLoS ONE, 2012, 7(6): e39445.

Please choose a citation manager

Content to export